Fig. 6
From: Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer
Validation of DEsrlncRNA pair-based signature with Zhongshan cohort. A The log rank test shown by Kaplan-Meier curves indicated a better overall survival for low-risk group in Zhongshan cohort (P < 0.001) B The TIDE value was significantly decreasing in low-risk group, confirming a better response potential to immunotherapy. (Mann-Whitney U test. **p < 0.01). C As for chemotherapy response, a lower risk score was also observed in patients diagnose as major response, but the result was not statistically significant. (Kruskal-Wallis test. ns for not significant)